Abstract
Proteomics is a field of study that characterises a complete profile of proteins present in a given cell, tissue or biological system. Recent advances in proteomics research made possible the identification of novel biomarkers and therapeutic targets in neurodegenerative diseases. The field of neurodegenerative diseases is particularly well suited for proteomic analysis, given the multifactorial nature of the diseases and complexity of the nervous system. As increasing evidence indicates that microglia-associated chronic neuroinflammation plays an important role in the pathophysiology of neurodegenerative diseases, microglial activation may be a potential drug target in CNS disorders. On the basis of both the neuroprotective and neurotoxic role of microglia, the proteomic analysis of microglial signalling and neuroinflammation may thus be used for the identification and validation of novel drug targets as well as for the discovery of useful biomarkers of disease diagnosis and progression in the CNS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
